Ildong

Bio & Pharma Ildong Pharma to spin off R&D subsidiary in Nov

South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1.&nbs...

Bio & Pharma Ildong Pharma to export high blood pressure treatment to China

South Korea's Ildong Pharmaceutical Co. on Tuesday said it will export benidipine hydrochloride, a raw material used in the treatment of high blood ...

Bio & Pharma Ildong Bioscience gets US FDA OK for probiotic raw materials

South Korea's Ildong Bioscience on Thursday said two of its probiotic raw materials received the certification generally recognized as safe (GRAS) f...

COVID-19 Ildong mulls seeking COVID-19 pill approval from Korea first

Ildong Pharmaceutical Co., a South Korean drugmaker, considers seeking approval for a COVID-19 anti-viral pill from the country as Japan postponed g...

Bio & Pharma Korean drugmakers close to commercializing COVID-19 vaccine, pill

South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...